Free tool
Oncology stocks
We cover 1 company grouped under the Oncology theme. The median market value in the group is $31.19M. Across the group, the median move over the past trading day is +1.61%. Price change over the past year runs from −57.4% to −57.4% across the middle 80 percent of the group, with a median of −57.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 319 matches these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 4582.T | SymBio Pharmaceuticals Limited | $31.19M | Micro cap | −57.43% | Oct 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.